# The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes Mellitus

> **NCT07685015** · NA · RECRUITING · sponsor: **Medical University of Vienna** · enrollment: 40 (estimated)

## Conditions studied

- Gestational Diabetes Mellitus (GDM)

## Interventions

- **DIETARY_SUPPLEMENT:** Myo-inositol 2 g + Folic acid 200 µg
- **DIETARY_SUPPLEMENT:** Folic acid 200 µg
- **DRUG:** Insulin therapy
- **BEHAVIORAL:** Nutrition therapy

## Key facts

- **NCT ID:** NCT07685015
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685015, "The Impact of Myo-Inositol on Glycemic Control and Oxidative Stress in Gestational Diabetes Mellitus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*